Maimonides Minocycline in Stroke Study

PHASE2,PHASE3

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped The protocol is in the process to change due to challenges in recruiting participants (without a treatment arm) which is now reflected in 2024-04-01

Conditions

Stroke, Acute
Ischemic Stroke
Hemorrhagic Stroke
Mortality
Morbidity

Interventions

DRUG: Minocycline

Sponsor

Maimonides Medical Center